Stay updated on Sacituzumab Govitecan in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating the study details are temporarily unavailable; the UI shows a minimal 403 page with a header and navigation.
    Difference
    20%
    Check dated 2026-09-21T22:10:35.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study is no longer recruiting participants, and the total number of participating locations has decreased due to site removals.
    Difference
    3%
    Check dated 2026-09-07T20:29:18.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6 on the page. This indicates a new build/update of the page, with no substantive content changes implied.
    Difference
    0.0%
    Check dated 2026-08-31T16:20:09.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The study's external identifiers now include an NIH grant/contract entry for 2023, reflecting NIH funding attribution.
    Difference
    0.0%
    Check dated 2026-08-24T16:42:02.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Instead of the trial details, the page now displays a 500 error indicating the service is unavailable. This renders the TROPHY U-01 study record on ClinicalTrials.gov inaccessible until the issue is resolved.
    Difference
    20%
    Check dated 2026-08-10T10:16:44.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    - The page revision label changed from v3.6.3 to v3.6.4, indicating a small update to the version history; this does not modify content or functionality.
    Difference
    0.0%
    Check dated 2026-07-26T18:57:29.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.